论文部分内容阅读
目的:评价参附注射液配合常规西医治疗慢性阻塞性肺疾病急性加重期的临床疗效。方法:将符合纳入标准的67例分为治疗组与对照组,两组均予西医常规治疗,治疗组加用参附注射液,观察两组的治疗效果。结果:治疗组总体疗效和咳、痰、喘症状改善均优于对照组(P<0.05),而肺部罗音的改善与对照组无显著性差异(P>0.05)。结论:参附注射液能提高AECOPD的临床疗效。
Objective: To evaluate the clinical effect of Shenfu injection combined with routine Western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease. Methods: Sixty-seven cases which met the inclusion criteria were divided into treatment group and control group. Both groups were treated routinely with Western medicine. The treatment group was treated with Shenfu injection to observe the therapeutic effect of the two groups. Results: The overall curative effect and improvement of cough, sputum and asthma symptoms in the treatment group were better than those in the control group (P <0.05). However, there was no significant difference between the improvement of lung rales and the control group (P> 0.05). Conclusion: Shenfu injection can improve the clinical efficacy of AECOPD.